Fingerprint
Dive into the research topics where Jonathan Cohen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Burnout in Oncology Clinical Research Coordinators: Underlying Factors and Role of Empathy as a Moderator
Kidron, A., Ben-Dor, R., Otap, D., Barsky, I. & Cohen, J. E., 2026, (Accepted/In press) In: JCO Oncology Practice.Research output: Contribution to journal › Article › peer-review
-
Impact of COVID-19 on cutaneous squamous cell carcinoma severity in a tertiary referral center in Israel: Lessons for future pandemics
Korn, D., Sheffer-Levi, S., Eitan-Wexler, M., Ben-Shushan, S., Avner, M., Hirshhorn, N., Bracha, M., Mali, A., Shereberk-Hasidim, R., Merims, S., Popovtzer, A., Molho-Pessach, V., Lotem, M. & Cohen, J. E., Feb 2026, In: JAAD International. 24, p. 1-3 3 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentation
Sagie, S., Babu, T., Weller, C., Tabachnik, C., Livneh, I., Quast, N. P., Gumpert, N., Shomuradova, A., Raybould, M. I., Levy, R., Malko, D., Alfia, A., Ben Lulu, T., Alon, M., Herrera, F., Kutuzov, M., Zerbib, M., Greenberg, P., Wasserman-Bartov, T. & Benedek, G. & 12 others, , 16 Dec 2025, In: Cell Reports Medicine. 6, 12, 102506.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB–D melanoma: a phase 1/2 trial
Dummer, R., Robert, C., Scolyer, R. A., Taube, J. M., Tetzlaff, M. T., Menzies, A. M., Hill, A., Grob, J. J., Portnoy, D. C., Lebbe, C., Khattak, M. A., Cohen, J., Bar-Sela, G., Mehmi, I., Shapira-Frommer, R., Meyer, N., Webber, A. L., Ren, Y., Fukunaga-Kalabis, M. & Krepler, C. & 1 others, , Jan 2025, In: Nature Medicine. 31, 1, p. 144-151 8 p., eaar3593.Research output: Contribution to journal › Article › peer-review
Open Access31 Scopus citations -
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
Yaeger, R., McKean, M. A., Haq, R., Beck, J. T., Taylor, M. H., Cohen, J. E., Bowles, D. W., Gadgeel, S. M., Mihalcioiu, C., Papadopoulos, K. P., Diamond, E. L., Sturtz, K. B., Feng, G., Drescher, S. K., Reddy, M. B., Sengupta, B., Maity, A. K., Brown, S. A., Singh, A. & Brown, E. N. & 11 others, , 1 Sep 2024, In: Cancer Discovery. 14, 9, p. 1599-1611 13 p.Research output: Contribution to journal › Article › peer-review
Open Access22 Scopus citations